The association of Il17ra/IL17RA with monophasic-EAE incidence is plausible, given the involvement of IL-17 and Th17 cells in MS/EAE pathogenesis (57, 58), particularly CIS and early MS (59, 60). The gene discussed is IL17A; the disease is in situ carcinoma.